SEC Form 4 · accession 0001140361-16-075598
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Wareham
Director
Period of report
Aug 8, 2016
Accepted (ET)
Aug 10, 2016 · 12:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Aug 8, 2016 | M | 24,390 | $33.70 | A | 37,390 | D | |
| ResMed Common StockF1 | Aug 8, 2016 | S | 24,390 | $70.315 | D | 13,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | Aug 8, 2016 | M | 24,390 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Commmon Stock | 24,390 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $70.23 to $70.42. The price reported above reflects the weighted average sale price.
- F2Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholder's meeting following grant date.